Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

Global Trial to Test Lifestyle Plus Metabolic Tx in Dementia

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

Compounded GLP-1s Still Widespread Despite Shortage Fix

The compounded GLP-1 market continues, even though some suppliers lack sterile-compounding licenses or have faced disciplinary action, and many add ingredients such as B vitamins.

Glucose, A1c Mediate Obesity-Pancreatic Cancer Link

Higher BMI, waist size, and waist-hip ratio are linked to an increased risk for pancreatic cancer, and part of the association is explained by poor glycaemic control, a study finds.

Alcohol and Marijuana Use in Type 1 Diabetes: What to Know

People with type 1 diabetes are just as likely to use substances as the rest of the population, so they need to be aware of the risks and how to mitigate them.

Semaglutide Tied to Lower Risk for Adult-Onset Seizure

In adults with type 2 diabetes, semaglutide initiation was associated with roughly half the risk for adult-onset seizure compared with other glucose-lowering medications — a protective effect that appeared independent of blood sugar or weight control.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

The compounded GLP-1 market continues, even though some suppliers lack sterile-compounding licenses or have faced disciplinary action, and many add ingredients such as B vitamins.

Higher BMI, waist size, and waist-hip ratio are linked to an increased risk for pancreatic cancer, and part of the association is explained by poor glycaemic control, a study finds.

People with type 1 diabetes are just as likely to use substances as the rest of the population, so they need to be aware of the risks and how to mitigate them.

In adults with type 2 diabetes, semaglutide initiation was associated with roughly half the risk for adult-onset seizure compared with other glucose-lowering medications — a protective effect that appeared independent of blood sugar or weight control.

News All Time

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Do Infant Food Portion Sizes Matter for Later Overweight?

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Semaglutide Linked to Rare Brain Illness

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

Screening for Diabetes at Urgent Care Could Save Lives

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.

Androgen Blood Test May Help Diagnose Endometriosis

Women with endometriosis show a distinct blood androgen profile that distinguishes them from women without the disease, pointing to a possible future noninvasive test.

Women Wait Longer Than Men for a Thyroid Disease Diagnosis

Some symptoms of hypothyroidism and hyperthyroidism overlap with those of other conditions and diseases, which makes differential diagnosis challenging.

Two Dietary Fibers May Cut Crohn’s Risk in Certain Patients

Eating more dietary fibers such as beta-glucan and inulin is linked to a lower risk for Crohn’s disease in first-degree relatives of patients with Crohn’s disease.

Ovarian Cancer: Can Repurposed Drugs Work Better Together?

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

Acromegaly Tied to Elevated Colorectal, Thyroid Cancer Risk

Acromegaly is tied to a higher risk for colorectal cancer and benign colorectal lesions, but the overall long-term cancer risk and cancer-related mortality remain comparable to the general population.

First Non-Hormonal Menopause Drug Approved in Scotland

The Scottish Medicines Consortium has accepted fezolinetant for restricted use within NHS Scotland for menopausal vasomotor symptoms in women who cannot take hormone therapy.

Guidance Aids Adjunctive Incretin Use in Type 1 Diabetes

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label prescribing.

Can Sniffing Chocolate Boost Leg Workout Performance?

Sniffing chocolate before performing sets of leg extensions may modulate appetite and increase overall training volume without raising perceived exertion.

GLP-1 RA Drugs Tied to Menstrual Disruptions

Semaglutide in particular is associated with reporting of adverse menstrual events; liraglutide shows no such association.

Chronic Diseases Linked to Worse Biliary Endoscopy Outcomes

The presence of chronic kidney disease, heart failure, or cirrhosis is linked to increased odds of inpatient death and complications after endoscopic bile duct procedures.

1 in 9 Americans Now on GLP-1s

A recent Gallup poll shows that the use of GLP-1 drugs in the US has surged to a record high, with 11% of US adults currently using these medications and 15% reporting having used them at some point.

Manometry May Detect Hidden Reflux in Obesity

High-resolution impedance manometry identifies physiologic evidence of reflux in many patients with obesity whose gastroesophageal reflux disease may be missed on the basis of symptoms alone.

Recommended News For You

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

Healthcare in the Mix in President Biden's Farewell Address

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance

Detecting pancreatic cancer through changes in body composition and metabolism

Recommended Articles For You

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

Genetic Screening: A Game Changer in Cancer Prevention 

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options  

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

2.

Climate change is expected to increase the number of suicide deaths

3.

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

4.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

5.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

1.

Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology

2.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

3.

New Anticoagulants: Balancing Efficacy and Safety in Patients with Atrial Fibrillation

4.

Cancer Cachexia: Emerging Therapeutic Strategies

5.

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

3.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

4.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

5.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot